– EMERALD Study will investigate the safety and efficacy of RTX001, an engineered macrophage cell therapy, in patients with end-stage liver disease – Recruitment already underway in the U.K., following recent MHRA approval EDINBURGH, Scotland and LONDON, Nov. 19, 2024 /PRNewswire/ –…